Follow
Nadeen T Ali
Nadeen T Ali
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)
DL Hertz, DS Childs, SB Park, S Faithfull, Y Ke, NT Ali, SM McGlown, ...
Cancer treatment reviews 99, 102241, 2021
382021
Risk factors associated with venous thromboembolism in breast cancer: a narrative review
ZA Razouki, NT Ali, VQ Nguyen, CP Escalante
Supportive Care in Cancer 30 (10), 8589-8597, 2022
62022
The incidence of oxaliplatin-induced peripheral neurotoxicity at Khartoum oncology hospital: a cross-sectional survey
NT Ali, AA Mohamed, BA Yousef
Asia-Pacific Journal of Oncology Nursing 7 (3), 266-272, 2020
52020
Peripheral neuropathy and cognitive impairment caused by platinum-based chemotherapy
HR Wardill, YZA Van Sebille, NT Ali, LB Grech
Platinum-Based Chemotherapy: Clinical Uses, Efficacy and Side Effects, 101-156, 2022
2022
Inpatient primary prophylaxis of cancer-associated thromboembolism (CAT)
TW Butler, NT Ali, MJ Spalek, S Scott, N Tsoukalas
Supportive Care in Cancer 30 (10), 8501-8509, 2022
2022
Treatment and secondary prophylaxis of venous thromboembolism in cancer patients
NT Ali, A Young
Supportive Care in Cancer 30 (10), 8519-8526, 2022
2022
ASSESSMENT OF INCIDENCE AND MANAGEMENT OF OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY AT KHARTOUM ONCOLOGY HOSPITAL, 2019.
BAY ,Nadeen T. Ali, Amel A Mohamed
MASCC/ISOO Annual Meeting 2021, 2021
2021
Protocol for Systematic Review and Meta-Analysis on the Efficacy and Safety of Tocilizumab
AA Elnour, A Sadeq, FH Farah, IY Khidir, D Nassar, IM Abd, JA Allah, ...
Systematic Reviews in Pharmacy 11 (11), 2020
2020
Protocol for a Systematic Review and Meta-Analysis on Randomized Clinical Trials on the Efficacy and Safety of Sphingosine-1-Phosphotase Receptor Modulators
AA Elnour, A Sadeq, FH Farah, NA Kassem, H Abdulsamad, ...
Systematic Reviews in Pharmacy 11 (11), 1253-1262, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–9